Clinical Trial

The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme

Study acronym: SALTIRE
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to understand the processes of what causes and accelerates the disease progress in aortic stenosis and following aortic valve replacement. Participants will undergo transthoracic echocardiography every 6 months, with annual visits for state-of-the-art scanning techniques including positron-emission tomography combined with computed tomography or magnetic resonance imaging with radiotracers designed to look at disease processes including fibrosis, calcification, inflammation and thrombosis activity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-09-14; most recent amendment 2025-09-16.
Trial Details
NCT Number NCT06047561
Lead Sponsor University of Edinburgh
Conditions Aortic Stenosis
Enrollment 300 participants
Start Date 2023-05-22
Primary Completion 2028-05-22 (estimated)
Study Completion 2028-05-22 (estimated)
Updated on ClinicalTrials.gov 2025-09-17